Operating founders

A team working together for over 5 years.

Paul KAUFFMANN

Paul KAUFFMANN

Business Development

President

Paul, our CEO, is in charge of sales and marketing. After a PhD in magnetism applied to biomanipulation in Grenoble, Paul evolved internationally in the US and in France in two start-up companies mainly focused on cell manipulation and innovative high throughput screening solutions. In December 2014, he returned to Grenoble to join our group and launch the start-up.

Cédric BRUIX

Cédric BRUIX

Finance & Operations

Managing director

After graduating from ESSEC Business School (Paris), Cédric worked at Banque Paribas in France and in New York in structured finance transactions. In 1999, he joined the European private equity investor, Argos Soditic, where he spent 17 years (inc.10 years as partner) leading investments in France and in Switzerland. Cédric joined MagIA diagnostics in 2017 as CFO and COO.

Sarah DELSHADI

Sarah DELSHADI

Research & Development

Managing director

Sarah, the biologist of the team was  trained in in vitro diagnostics. In 2013, she developed a biomolecular test for infectious diseases at the Institut Pasteur (Madagascar). During her PhD (IAB and G2ELab), she developed the protocol which is now used in the MagIA immunoassay. Since 2017, she is in charge of the Research & Development (RD) efforts and Regulatory Affairs (RA).

Mario FRATZL

Mario FRATZL

Industrial Development

VP

Mario joined the MagIA diagnostics team in spring 2015 as a masters student. He is a mechanical and process engineer by training and possesses strong skills in microfluidics. During his PhD, he worked on the micromagnetic structures as well as the microfluidic cartridge concept. Since 2018, he is in charge of the industrialization and production of the cartridge at MagIA diagnostics.

Guillaume BLAIRE

Guillaume BLAIRE

Innovation

VP 

Guillaume co-invented the MagIA diagnostics technology during his PhD in Grenoble. After majoring in physics, Guillaume developed a profound interest in biophysics. An interdisciplinary project between the founders’ labs offered him the possibility to explore the potential of micromagnetism in immunological research. After developing major parts of the technology, he is now strengthening the innovative approaches of the company.

Team

Bond by a shared vision based on common values

Board

Philippe HALFON

Philippe HALFON

Philippe Halfon MD, PharmD, is the founder of several biotechnology companies based on the development of antiviral drugs (ACTgene & Genoscience Pharma). He is the head of the internal medicine department of the European Hospital of Marseille. He is also in charge of the R&D at Marseille Central Labs AlphaBio

Ronald DELAGRANGE

Ronald DELAGRANGE

Ronald Delagrange is the former CEO of MacoPharma. He is bringing to MagIA diagnostics his strong knowledge in the Medical Device industrial field, as well as his network among financial investors.

Non operating founders

Orphée CUGAT

Orphée CUGAT

G2Elab

Franz BRUCKERT

Franz BRUCKERT

LMGP

Academic partners

Nora DEMPSEY

Nora DEMPSEY

Institut Néel

Patrice MARCHE

Patrice MARCHE

IAB